|3 Months Ended|
Mar. 31, 2021
|NOTE K - CONCENTRATIONS||
Revenue from the Company’s Remote Power Patent from one licensee constituted 100% of the Company’s revenue for the three months ended March 31, 2021. Revenue from five licensees constituted approximately 99% of the Company’s revenue for the three months ended March 31, 2020. At March 31, 2021, one licensee constituted 100% of the Company’s royalty receivables and at December 31, 2020 the Company had no royalty receivables.
The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef